Finding the right treatment for hard-to-treat childhood blood cancers

This trial creates an international team of cancer experts who review detailed information about your tumor — including genetic tests and lab results — to recommend the best available treatment option for you. The goal is to match young people with relapsed or hard-to-treat blood cancers to therapies that are most likely to work based on what makes their cancer unique.

When blood cancers return or stop responding to standard chemotherapy, doctors have limited treatment options, and those options differ depending on the type of cancer. By gathering tumor information from young patients across Europe and discussing it with specialists, this trial aims to find better, more personalized treatment paths for these difficult cases.